Presentation is loading. Please wait.

Presentation is loading. Please wait.

Asthma, influenza, and vaccination

Published byUlf Johansson Modified over 5 years ago

Similar presentations

Presentation on theme: "Asthma, influenza, and vaccination"— Presentation transcript:

1 Asthma, influenza, and vaccination
W. Paul Glezen, MD  Journal of Allergy and Clinical Immunology  Volume 118, Issue 6, Pages (December 2006) DOI: /j.jaci Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions

2 Fig 1 Annual rates of influenza-attributable hospitalizations in the United States, Solid blue bars indicate years that influenza A(H3N2) viruses were predominant. Adapted with permission from Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292: Copyright © 2004, American Medical Association. All rights reserved. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions

3 Fig 2 Hospitalization rates by age group for acute respiratory conditions experienced by middle-income and low-income patients with chronic underlying conditions and for subsets with chronic pulmonary disease. Reprinted with permission from Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;283: Copyright © 2000, American Medical Association. All rights reserved. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions

4 Fig 3 Proportions of patients with chronic underlying conditions hospitalized for acute respiratory conditions who had infections with respiratory syncytial, influenza, or parainfluenza viruses by age in Houston, Tex, 1991 to Reprinted with permission from Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;283: Copyright © 2000, American Medical Association. All rights reserved. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Download ppt "Asthma, influenza, and vaccination"

Similar presentations

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Ovalbumin content of influenza vaccines

Ovalbumin content of influenza vaccines
D-dimer: A biomarker for antihistamine-resistant chronic urticaria

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection  Howard M. Rosenblatt,

Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection  Howard M. Rosenblatt,
Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies  Kathrin M. Cresswell, MSc, Aziz Sheikh,

Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies  Kathrin M. Cresswell, MSc, Aziz Sheikh,
Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score  Robert S. Zeiger, MD, PhD, Michael Mellon, MD, Bradley.

Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score  Robert S. Zeiger, MD, PhD, Michael Mellon, MD, Bradley.
Pharmacologic rationale for treating allergic and nonallergic rhinitis

Pharmacologic rationale for treating allergic and nonallergic rhinitis
Asthma exacerbations: Origin, effect, and prevention

Asthma exacerbations: Origin, effect, and prevention
Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies  Kathrin M. Cresswell, MSc, Aziz Sheikh,

Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies  Kathrin M. Cresswell, MSc, Aziz Sheikh,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D

Ann-Marie M. Schoos, MD, PhD, Jacob D
Advances in pediatric asthma in 2011: Moving forward

Advances in pediatric asthma in 2011: Moving forward
Jan Lötvall, MD, Cezmi A. Akdis, MD, Leonard B

Jan Lötvall, MD, Cezmi A. Akdis, MD, Leonard B
Disparities in allergic disease: Hypersensitivity and social disorders

Disparities in allergic disease: Hypersensitivity and social disorders
Biologics in patients with skin diseases

Biologics in patients with skin diseases
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Jack Pepys' contributions to the medical literature

Jack Pepys' contributions to the medical literature
Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012  Anni Nørgaard Jeppesen, MD, Christian Fynbo.

Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012  Anni Nørgaard Jeppesen, MD, Christian Fynbo.

Similar presentations

Ads by Google